The GLP-1 medications have known side effects but are largely safe based on experience with diabetic patients and well-tolerated by most people
If so, even though it would still be a small effect in a narrow demographic, that means that it could help more people at a significantly lower cost
A 2026 preclinical study in porcine models confirmed 50% faster re-epithelialization via EGFR activation (Wang et al., 2026)
Furthermore, it promotes heart health, decreases blood pressure, and lowers the chance of developing type 2 diabetes
3 Results 3.1 Subject Demographics Following the decision to reduce the semaglutide dose from 10 g/kg to 0.5 mg, a total of 56 subjects were exposed to a single 0.5 mg dose of semaglutide
While the outcome remains uncertain, patients who have relied on compounded semaglutide should plan for alternative long-term solutions, as a return to compounding remains very unlikely under current regulations
/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788239.jpeg)
